Eptaplatin

依铂

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEptaplatin
Drug Alias NameHeptaplatinSunplaNSC-644591SKI-2053RNSC-D-644591
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[4] 
Global Approved IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date1999/07/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSk Chemicals
China Registration ClassN/A

Develop Information

Active CompaniesSk Chemicals
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL01XA
Related LinksN/A